MELBOURNE, Australia and SAN FRANCISCO, March 02, 2026 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing ...
A Midlothian mum has opened up on the day her 'life changed' at being told she is dying. Angela Lynch, 54, was diagnosed with Multiple System Atrophy (MSA) in 2023 - a rare, degenerative and ...
Teva’s Emrusolmin Granted U.S. FDA Fast Track Designation for Treatment of Multiple System Atrophy
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results